Clinical Trial Update: A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for QL1706 in combination with bevacizumab and/or chemotherapy as first-line therapy for advanced hepatocellular carcinoma is in Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• QL1706

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING